-
1
المؤلفون: Katarzyna Kolasa, Cezary Sciborski, Phil McEwan, Leszek Czupryniak, Isabelle Duprat Lomon, Władysław Grzeszczak
المصدر: Diabetes Technology & Therapeutics. 14:65-73
مصطلحات موضوعية: Male, medicine.medical_specialty, Cost effectiveness, Cost-Benefit Analysis, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Insulin, Isophane, Adamantane, NPH insulin, Type 2 diabetes, Saxagliptin, chemistry.chemical_compound, Endocrinology, Diabetes mellitus, Internal medicine, medicine, Humans, Hypoglycemic Agents, Glycated Hemoglobin, Dipeptidyl-Peptidase IV Inhibitors, business.industry, Insulin, Type 2 Diabetes Mellitus, Dipeptides, Middle Aged, medicine.disease, Metformin, Medical Laboratory Technology, Models, Economic, Sulfonylurea Compounds, Diabetes Mellitus, Type 2, chemistry, Drug Therapy, Combination, Female, Poland, Quality-Adjusted Life Years, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2aabf8fda99080d04d76581547510f69Test
https://doi.org/10.1089/dia.2011.0092Test -
2
المؤلفون: George Dailey, Poul Strange, Matthew C. Riddle
المصدر: Diabetes Technology & Therapeutics. 11:477-479
مصطلحات موضوعية: Blood Glucose, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Insulin, Isophane, Insulin Glargine, NPH insulin, Type 2 diabetes, Hypoglycemia, Endocrinology, Internal medicine, Diabetes mellitus, medicine, Humans, Hypoglycemic Agents, Insulin, In patient, Intensive care medicine, Insulin glargine, business.industry, Treat to target, medicine.disease, Insulin, Long-Acting, Medical Laboratory Technology, Sulfonylurea Compounds, Diabetes Mellitus, Type 2, Glucagon Injection, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4b2446f8ec0cca8311a25e32d6075b8Test
https://doi.org/10.1089/dia.2009.0022Test